Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Controlled Clinical Trials as Topic MeSH Descriptor Data 2025


MeSH Heading
Controlled Clinical Trials as Topic
Tree Number(s)
E05.318.372.250.250.365
N05.715.360.330.250.250.365
N06.850.520.450.250.250.365
Unique ID
D018849
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D018849
Annotation
for general design, methodology, economics, etc. of clinical trials; a different heading CONTROLLED CLINICAL TRIAL is used for reports of a specific clinical trial
Scope Note
Works about clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.
Entry Term(s)
Clinical Trials, Controlled as Topic
Previous Indexing
Clinical Trials (1980-1994)
See Also
Control Groups
Public MeSH Note
2008; see CONTROLLED CLINICAL TRIALS 1995-2007,was see CLINICAL TRIALS 1980-1994
History Note
2008(1995); use CLINICAAL TRIALS 1980-1984
Date Established
1995/01/01
Date of Entry
1994/06/30
Revision Date
2018/07/02
Controlled Clinical Trials as Topic Preferred
page delivered in 0.143s